Name: FERMENTA BIOTECH LIMITED Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 671 across all filing types

Latest filing 2019-11-13 Regulatory Filings

Country IN India

Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing	Released	Lang
Pursuant to Regulation 42 of the Listing Regulations, the Board has approved the payment of interim Dividend of Rs. 5 (Five) per equity share of Rs. 5 each (100%) for the financial year .... Regulatory Filings	2019-11-13	English
Further to our intimation regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2019, .... Earnings Release Q2 2020	2019-11-13	English
The Board has approved the unaudited financial results for the quarter and half year ended September 30, 2019 (Standalone and Consolidated), as enclosed. We are enclosing herewith .... Regulatory Filings	2019-11-13	English
Pursuant to Regulation 30 and 33 of Listing Regulations, we write to inform you that the Board of Directors of the Company at its meeting held on November 13, 2019 has, inter alia, approved .... Regulatory Filings	2019-11-13	English
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Notice of 'Listing and Trading of New .... Regulatory Filings	2019-11-11	English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide .... Regulatory Filings	2019-11-07	English

Browse filings by year

8 years

	ID	Filing	Released	Lang
2019 15 filings
	45996628	Pursuant to Regulation 42 of the Listing Regulations, the Board has approved the payment of interim Dividend of Rs. 5 (Five) per equity share of Rs. 5 each (100%) for the financial year .... Regulatory Filings	2019-11-13	English
	45996620	Further to our intimation regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2019, .... Earnings Release Q2 2020	2019-11-13	English
	45996625	The Board has approved the unaudited financial results for the quarter and half year ended September 30, 2019 (Standalone and Consolidated), as enclosed. We are enclosing herewith .... Regulatory Filings	2019-11-13	English
	45996631	Pursuant to Regulation 30 and 33 of Listing Regulations, we write to inform you that the Board of Directors of the Company at its meeting held on November 13, 2019 has, inter alia, approved .... Regulatory Filings	2019-11-13	English
	45996676	In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Notice of 'Listing and Trading of New .... Regulatory Filings	2019-11-11	English
	45996652	Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide .... Regulatory Filings	2019-11-07	English
	45996635	Intimation of Investor Relations Presentation - Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a .... Investor Presentation	2019-11-06	English
	45996638	DIL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve the unaudited financial results of the .... Regulatory Filings	2019-11-04	English
	45996649	Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018 for the quarter ended September 30, 2019 ('Period') Please find enclosed herewith .... Regulatory Filings	2019-10-30	English
	45996670	Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated October 11, 2019 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the half year .... Regulatory Filings	2019-10-24	English
	45996657	Compliance Certificate - Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') .... Regulatory Filings	2019-10-23	English
	45996661	Intimation regarding change of name from DIL Limited to Fermenta Biotech Limited pursuant to 'Scheme of Amalgamation of Fermenta Biotech Limited (the Transferor Company) with DIL Limited .... Regulatory Filings	2019-10-17	English
	45996664	Intimation about the Allotment of 637,537 equity shares (New Securities) of the face value of INR.5/- (Rupees Five only) each, fully paid-up to the members of Fermenta Biotech Limited, .... Share Issue/Capital Change	2019-10-11	English
	45996682	Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting .... Investor Presentation	2019-10-10	English
	45996666	Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading, and BSE circular no. LIST/COMP/01/2019-20 .... Regulatory Filings	2019-10-01	English

Page 41 of 45

Prev … 39 40 41 42 43 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

FERMENTA BIOTECH LIMITED via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID60716

TickerFERMENTA

ISININE225B01021

Endpoints

most-used routes for this company

GET	/api/companies/60716/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=60716	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=60716	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for FERMENTA BIOTECH LIMITED

$ curl https://api.financialreports.eu/api/filings/?company=60716 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 60716},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for FERMENTA BIOTECH LIMITED (id: 60716)"

FERMENTA BIOTECH LIMITED — Investor Relations & Filings